What is the current valuation of the GCC Biopsy Devices Market?

As of 2024, the market valuation was 70.25 USD Million. Read More

What is the projected market size for the GCC Biopsy Devices Market by 2035?

The market is expected to reach a valuation of 129.55 USD Million by 2035. Read More

What is the expected CAGR for the GCC Biopsy Devices Market during the forecast period?

The market is projected to grow at a CAGR of 5.72% from 2025 to 2035. Read More

Which application segment holds the highest market value in the GCC Biopsy Devices Market?

The Cancer Diagnosis segment is anticipated to have the highest market value, ranging from 30.0 to 55.0 USD Million. Read More

What are the key device types in the GCC Biopsy Devices Market?

Key device types include Needle Biopsy Devices, Surgical Biopsy Devices, Vacuum-Assisted Biopsy Devices, and Fine Needle Aspiration Biopsy Devices. Read More

Which end-user segment is expected to dominate the GCC Biopsy Devices Market?

Hospitals are projected to dominate the market, with a valuation between 30.0 and 55.0 USD Million. Read More

What technological advancements are influencing the GCC Biopsy Devices Market?

Technologies such as Ultrasound-Guided Biopsy and Endoscopic Biopsy are likely to drive market growth, with valuations of 20.0 to 37.0 USD Million and 25.25 to 47.55 USD Million, respectively. Read More

What is the market outlook for the Fine Needle Aspiration Biopsy Devices segment?

The Fine Needle Aspiration Biopsy Devices segment is expected to grow significantly, with a projected valuation between 25.25 and 50.55 USD Million. Read More

How does the GCC Biopsy Devices Market compare across different device types?

The Needle Biopsy Devices segment is projected to range from 20.0 to 36.0 USD Million, indicating a competitive landscape among device types. Read More

GCC Biopsy Devices Market

Q: Who are the leading players in the GCC Biopsy Devices Market?

Key players include Medtronic, Boston Scientific, Becton Dickinson, Hologic, and Cook Medical. Read More

ID: MRFR/HC/54677-HCR

200 Pages

Satyendra Maurya

Last Updated: May 12, 2026

GCC Biopsy Devices Market Research Report: By Product Type (Biopsy Guns, Biopsy Guidance System, Biopsy Needles, Biopsy Forceps, Localization Wires, Others), By Application (Breast Biopsy, Prostate Biopsy, Liver Biopsy, Lung Biopsy, Gynecological Biopsy, Others), By Guidance (Ultrasound-Guided Biopsy, Stereotactic Guided Biopsy, MRI-Guided Biopsy, CT Guided Biopsy, Others) andBy End User (Hospitals & Clinics, Diagnostic & Imaging Centers, Academic & Research Institutes, Others)- Forecast to 2035

GCC Biopsy Devices Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)5.72%

2018 Market Size$ 132 Million

2024 Market Size$ 70.25 Million

2035 Market Size$ 129.55 Million

Key Players

Medtronic

Boston Scientific

Becton Dickinson

Hologic

Cook Medical

Olympus

Trends

Technological Advancements
Rising Demand for Minimally Invasive Procedures
Regulatory Support for Innovation

Opportunities

Increasing Incidence of Cancer
Growing Awareness and Education
Regulatory Support for Innovation

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 GCC Biopsy Devices Market, BY Application (USD Million) | |
  1. 4.1.1 Cancer Diagnosis | |
  2. 4.1.2 Infectious Disease Diagnosis | |
  3. 4.1.3 Transplantation | |
  4. 4.1.4 Autoimmune Disease Diagnosis |
2. 4.2 GCC Biopsy Devices Market, BY Device Type (USD Million) | |
  1. 4.2.1 Needle Biopsy Devices | |
  2. 4.2.2 Surgical Biopsy Devices | |
  3. 4.2.3 Vacuum-Assisted Biopsy Devices | |
  4. 4.2.4 Fine Needle Aspiration Biopsy Devices |
3. 4.3 GCC Biopsy Devices Market, BY End User (USD Million) | |
  1. 4.3.1 Hospitals | |
  2. 4.3.2 Diagnostic Laboratories | |
  3. 4.3.3 Research Institutions | |
  4. 4.3.4 Outpatient Clinics |
4. 4.4 GCC Biopsy Devices Market, BY Technology (USD Million) | |
  1. 4.4.1 Ultrasound-Guided Biopsy | |
  2. 4.4.2 CT-Guided Biopsy | |
  3. 4.4.3 MRI-Guided Biopsy | |
  4. 4.4.4 Endoscopic Biopsy 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the GCC Biopsy Devices Market | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the GCC Biopsy Devices Market | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Medtronic (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Boston Scientific (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Becton Dickinson (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Hologic (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Cook Medical (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Olympus (JP) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Siemens Healthineers (DE) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Fujifilm (JP) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 GE Healthcare (US) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 GCC MARKET ANALYSIS BY APPLICATION |
6. 6.3 GCC MARKET ANALYSIS BY DEVICE TYPE |
7. 6.4 GCC MARKET ANALYSIS BY END USER |
8. 6.5 GCC MARKET ANALYSIS BY TECHNOLOGY |
9. 6.6 KEY BUYING CRITERIA OF GCC BIOPSY DEVICES MARKET |
10. 6.7 RESEARCH PROCESS OF MRFR |
11. 6.8 DRO ANALYSIS OF GCC BIOPSY DEVICES MARKET |
12. 6.9 DRIVERS IMPACT ANALYSIS: GCC BIOPSY DEVICES MARKET |
13. 6.10 RESTRAINTS IMPACT ANALYSIS: GCC BIOPSY DEVICES MARKET |
14. 6.11 SUPPLY / VALUE CHAIN: GCC BIOPSY DEVICES MARKET |
15. 6.12 GCC BIOPSY DEVICES MARKET, BY APPLICATION, 2024 (% SHARE) |
16. 6.13 GCC BIOPSY DEVICES MARKET, BY APPLICATION, 2024 TO 2035 (USD Million) |
17. 6.14 GCC BIOPSY DEVICES MARKET, BY DEVICE TYPE, 2024 (% SHARE) |
18. 6.15 GCC BIOPSY DEVICES MARKET, BY DEVICE TYPE, 2024 TO 2035 (USD Million) |
19. 6.16 GCC BIOPSY DEVICES MARKET, BY END USER, 2024 (% SHARE) |
20. 6.17 GCC BIOPSY DEVICES MARKET, BY END USER, 2024 TO 2035 (USD Million) |
21. 6.18 GCC BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024 (% SHARE) |
22. 6.19 GCC BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024 TO 2035 (USD Million) |
23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
24. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
25. 7.2 GCC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million) | |
  2. 7.2.2 BY DEVICE TYPE, 2026-2035 (USD Million) | |
  3. 7.2.3 BY END USER, 2026-2035 (USD Million) | |
  4. 7.2.4 BY TECHNOLOGY, 2026-2035 (USD Million) |
26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
27. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

GCC Biopsy Devices Market Segmentation

GCC Biopsy Devices Market By Application (USD Million, 2022-2035)

Cancer Diagnosis
Infectious Disease Diagnosis
Transplantation
Autoimmune Disease Diagnosis

GCC Biopsy Devices Market By Device Type (USD Million, 2022-2035)

Needle Biopsy Devices
Surgical Biopsy Devices
Vacuum-Assisted Biopsy Devices
Fine Needle Aspiration Biopsy Devices

GCC Biopsy Devices Market By End User (USD Million, 2022-2035)

Hospitals
Diagnostic Laboratories
Research Institutions
Outpatient Clinics

GCC Biopsy Devices Market By GCC Biopsy Devices Market (USD Million, 2022-2035)

Ultrasound-Guided Biopsy
CT-Guided Biopsy
MRI-Guided Biopsy
Endoscopic Biopsy

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”